1. Home
  2. USCB vs ENGN Comparison

USCB vs ENGN Comparison

Compare USCB & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USCB
  • ENGN
  • Stock Information
  • Founded
  • USCB 2002
  • ENGN 1999
  • Country
  • USCB United States
  • ENGN Canada
  • Employees
  • USCB N/A
  • ENGN N/A
  • Industry
  • USCB Major Banks
  • ENGN
  • Sector
  • USCB Finance
  • ENGN
  • Exchange
  • USCB Nasdaq
  • ENGN Nasdaq
  • Market Cap
  • USCB 316.4M
  • ENGN 204.3M
  • IPO Year
  • USCB 2021
  • ENGN N/A
  • Fundamental
  • Price
  • USCB $17.00
  • ENGN $3.83
  • Analyst Decision
  • USCB Buy
  • ENGN Buy
  • Analyst Count
  • USCB 3
  • ENGN 7
  • Target Price
  • USCB $20.50
  • ENGN $23.29
  • AVG Volume (30 Days)
  • USCB 27.3K
  • ENGN 97.4K
  • Earning Date
  • USCB 07-24-2025
  • ENGN 06-12-2025
  • Dividend Yield
  • USCB 2.35%
  • ENGN N/A
  • EPS Growth
  • USCB 78.48
  • ENGN N/A
  • EPS
  • USCB 1.39
  • ENGN N/A
  • Revenue
  • USCB $84,457,000.00
  • ENGN N/A
  • Revenue This Year
  • USCB $23.28
  • ENGN N/A
  • Revenue Next Year
  • USCB $7.02
  • ENGN N/A
  • P/E Ratio
  • USCB $12.23
  • ENGN N/A
  • Revenue Growth
  • USCB 34.16
  • ENGN N/A
  • 52 Week Low
  • USCB $11.88
  • ENGN $2.65
  • 52 Week High
  • USCB $21.86
  • ENGN $11.00
  • Technical
  • Relative Strength Index (RSI)
  • USCB 59.44
  • ENGN 57.73
  • Support Level
  • USCB $16.08
  • ENGN $2.95
  • Resistance Level
  • USCB $17.80
  • ENGN $3.44
  • Average True Range (ATR)
  • USCB 0.48
  • ENGN 0.26
  • MACD
  • USCB 0.13
  • ENGN 0.08
  • Stochastic Oscillator
  • USCB 64.09
  • ENGN 82.86

About USCB USCB Financial Holdings Inc.

USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: